Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010

BACKGROUND: Biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic (ts) DMARDs are important in rheumatoid arthritis (RA) treatment. The risk of hospitalized infection associated with bDMARDs/tsDMARDs in RA patients is unclear. METHODS: We retrospectively analyzed the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichinose, Kunihiro, Shimizu, Toshimasa, Umeda, Masataka, Fukui, Shoichi, Nishino, Ayako, Koga, Tomohiro, Kawashiri, Shin-ya, Iwamoto, Naoki, Tamai, Mami, Nakamura, Hideki, Sato, Shuntaro, Origuchi, Tomoki, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112083/
https://www.ncbi.nlm.nih.gov/pubmed/30186881
http://dx.doi.org/10.1155/2018/6259010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112083/
https://www.ncbi.nlm.nih.gov/pubmed/30186881
http://dx.doi.org/10.1155/2018/6259010

Ejemplares similares